Halftime Report cover image

New Month, New Strategy 11/3/25

Halftime Report

00:00

Are Biotech and Pharma Attractive Now?

Frank references a bullish Roth Capital note; Carrie and Joe assess Amgen, Novo Nordisk and XBI positioning amid sector weakness and entry points.

Play episode from 29:26
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app